To confirm the decrease in inflammatory cell types during the peak of infection in NSC61610-treated mice, we measured the mRNA expression of inflammatory markers, IFNα, TNFα and MCP1, in the lungs of infected mice (Figures 4L–N). Here, CCL2 is linked to infection.